These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 8496806)

  • 1. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts.
    Grover GJ; Dzwonczyk S; Sleph PG; Sargent CA
    J Pharmacol Exp Ther; 1993 May; 265(2):559-64. PubMed ID: 8496806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of nitric oxide synthesis and ischemia/reperfusion attenuate coronary vasodilator response to pinacidil in isolated rat heart.
    Maczewski M; Beresewicz A
    J Physiol Pharmacol; 1997 Dec; 48(4):737-49. PubMed ID: 9444621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
    Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
    Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
    Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
    Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different preconditioning stimuli invoke disparate electromechanical and energetic responses to global ischemia in rat hearts.
    Rehring TF; Bender PR; Cairns CB; Joo K; Friese RS; Shapiro JI; Cleveland JC; Banerjee A
    Can J Physiol Pharmacol; 1997 Apr; 75(4):335-42. PubMed ID: 9196860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
    Tosaki A; Engelman DT; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
    Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
    J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role?
    Fujii M; Chambers DJ
    Eur J Cardiothorac Surg; 2005 Dec; 28(6):821-31. PubMed ID: 16242951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of G(alphaq/11) protein and ATP-sensitive potassium channels on prostaglandin E(1) preconditioning in rat hearts.
    Ma SG; Fu RF; Feng GQ; Wang ZJ; Ma XQ; Weng SA
    Acta Pharmacol Sin; 2004 May; 25(5):587-92. PubMed ID: 15132823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation.
    Ford WR; Lopaschuk GD; Schulz R; Clanachan AS
    Br J Pharmacol; 1998 Jun; 124(4):639-46. PubMed ID: 9690854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning in immature hearts: mechanism and compatibility with cardioplegia.
    Zhu B; Min S; Long C; Ye T
    Chin Med J (Engl); 2003 Feb; 116(2):253-7. PubMed ID: 12775242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
    Tosaki A; Szerdahelyi P; Engelman RM; Das DK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconditioning in globally ischemic isolated rat hearts: effect on function and metabolic indices of myocardial damage.
    Arad M; de Jong JW; de Jonge R; Huizer T; Rabinowitz B
    J Mol Cell Cardiol; 1996 Dec; 28(12):2479-90. PubMed ID: 9004164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
    Grover GJ; Sleph PG; Dzwonczyk S; McCullough JR
    J Pharmacol Exp Ther; 1993 Oct; 267(1):102-7. PubMed ID: 8229736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
    Johansen D; Ytrehus K; Baxter GF
    Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection?
    Menasché P; Kevelaitis E; Mouas C; Grousset C; Piwnica A; Bloch G
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1606-13; discussion 1613-4. PubMed ID: 8523870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of ischemia/reperfusion injury in isolated rats hearts by the ATP-sensitive potassium channel opener BMS-180448.
    Monticello TM; Sargent CA; McGill JR; Barton DS; Grover GJ
    Cardiovasc Res; 1996 Jan; 31(1):93-101. PubMed ID: 8849593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart.
    Fralix TA; Steenbergen C; London RE; Murphy E
    Cardiovasc Res; 1993 Apr; 27(4):630-7. PubMed ID: 8324797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.